Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mark FitzGerald

Showing results (261-270 of 325) with videos related to

Pageof 33
Sort By:
Biomarker Insights|September 30, 2017
Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow LimitationPhilip E Silkoff, Dave Singh, J Mark FitzGerald, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 19, 2008
Overdiagnosis of asthma in obese and nonobese adultsShawn D Aaron, Katherine L Vandemheen, Louis-Philippe Boulet, et al.
Drug Safety|February 6, 2021
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA StudiesJ Mark FitzGerald, Paul M O'Byrne, Eric D Bateman, et al.
The Lancet. Respiratory Medicine|June 28, 2021
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysisWilliam W Busse, Sally E Wenzel, Thomas B Casale, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 19, 2022
Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe AsthmaIan D Pavord, Yamo Deniz, Jonathan Corren, et al.
Proteomics. Clinical Applications|August 30, 2012
Plasma proteomics can discriminate isolated early from dual responses in asthmatic individuals undergoing an allergen inhalation challengeAmrit Singh, Gabriela V Cohen Freue, Jean L Oosthuizen, et al.
Plos One|July 12, 2013
Gene-metabolite expression in blood can discriminate allergen-induced isolated early from dual asthmatic responsesAmrit Singh, Masatsugu Yamamoto, Sarah H Y Kam, et al.
JAMA|January 24, 2017
Reevaluation of Diagnosis in Adults With Physician-Diagnosed AsthmaShawn D Aaron, Katherine L Vandemheen, J Mark FitzGerald, et al.
Annals of the American Thoracic Society|June 8, 2018
Between-Visit Variability in FEV<sub>1</sub> as a Diagnostic Test for Asthma in AdultsBenjamin W Dean, Erin E Birnie, George Alex Whitmore, et al.
American Journal of Respiratory and Critical Care Medicine|February 3, 2016
Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD StudyLaura E Labonté, Wan C Tan, Pei Z Li, et al.
Pageof 33

Showing results (261-270 of 325) with videos related to

Sort By:
Pageof 33
Biomarker Insights|September 30, 2017
Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow LimitationPhilip E Silkoff, Dave Singh, J Mark FitzGerald, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 19, 2008
Overdiagnosis of asthma in obese and nonobese adultsShawn D Aaron, Katherine L Vandemheen, Louis-Philippe Boulet, et al.
Drug Safety|February 6, 2021
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA StudiesJ Mark FitzGerald, Paul M O'Byrne, Eric D Bateman, et al.
The Lancet. Respiratory Medicine|June 28, 2021
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysisWilliam W Busse, Sally E Wenzel, Thomas B Casale, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 19, 2022
Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe AsthmaIan D Pavord, Yamo Deniz, Jonathan Corren, et al.
Proteomics. Clinical Applications|August 30, 2012
Plasma proteomics can discriminate isolated early from dual responses in asthmatic individuals undergoing an allergen inhalation challengeAmrit Singh, Gabriela V Cohen Freue, Jean L Oosthuizen, et al.
Plos One|July 12, 2013
Gene-metabolite expression in blood can discriminate allergen-induced isolated early from dual asthmatic responsesAmrit Singh, Masatsugu Yamamoto, Sarah H Y Kam, et al.
JAMA|January 24, 2017
Reevaluation of Diagnosis in Adults With Physician-Diagnosed AsthmaShawn D Aaron, Katherine L Vandemheen, J Mark FitzGerald, et al.
Annals of the American Thoracic Society|June 8, 2018
Between-Visit Variability in FEV<sub>1</sub> as a Diagnostic Test for Asthma in AdultsBenjamin W Dean, Erin E Birnie, George Alex Whitmore, et al.
American Journal of Respiratory and Critical Care Medicine|February 3, 2016
Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD StudyLaura E Labonté, Wan C Tan, Pei Z Li, et al.
Pageof 33